Motugivatrep introduces first-in-class topical TRPV1 antagonism for DED, targeting corneal nociceptor-driven discomfort ...

The systemic lupus erythematosus (SLE) market continues to evolve toward biologic-driven care, with increasing treatment complexity, intensifying competition among advanced therapies, and a robust ...

This Bengali language male bonding road trip dramedy is a great introduction to the legendary director's movies.

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company ...

Advances in precision fermentation and emerging adult clinical data are positioning human milk oligosaccharides as a new ...

The following decade proved challenging: despite recording with Steve Jansen as The Dolphin Brothers and briefly reforming ...

The Honda engine that redefined performance metrics in the automotive world demonstrated that high revs can outperform sheer ...

Heteroatom-doped carbon-based materials are acknowledged as a promising approach to enhance catalytic activity. In this study ...

Motor control ICs deliver higher efficiency, along with AI/ML functionality for improvements in predictive maintenance.

G is reaching a halfway point in its life. That implies we will have 6G by 2030, which seems to be a common thread, lately, in many of today’s 6G discussions.

Results from pediatric patients in the SAVE Registry shows no device-related adverse events or immunosuppression and continued strong survival ...

Biogen has announced a definitive agreement to acquire Apellis Pharmaceuticals for approximately $5.6 billion, a move that would expand its presence in complement-mediated diseases, including ...